MA

Active Director Director DIN 08503367
DIN 08503367 First appointment Jul 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Md Ashraf

Data last updated:

Md Ashraf is a Director at Sunlab Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Sunlab Pharmaceuticals Private Limited reported revenue of ₹78,502 (FY 2022).

DIN 08503367
Primary Designation Director
Industry Chemicals
First Appointment 08 Jul 2019
Oldest Company Age 7 yrs
Largest company Sunlab Pharmaceuticals Private Limited · ₹78,502 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jul 20192019₹78,502 (FY 2022)Active

Board colleagues of Md Ashraf

NameDINCompanyDesignation
Raj Kumar Rajak08503365Sunlab Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sunlab Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Md Ashraf

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Md Ashraf

Md Ashraf currently holds 1 directorship: Sunlab Pharmaceuticals Private Limited (Director, since 08 Jul 2019, revenue ₹78,502 (FY 2022)).

Md Ashraf was first appointed on 08 Jul 2019 as Director at Sunlab Pharmaceuticals Private Limited.

The current boards of Md Ashraf's companies include Raj Kumar Rajak (Sunlab Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available